Amanda Stark

Amanda Stark - Griffith Hack

BSc (Biochem) (Hons), Chartered Patent Agent (UK), European Patent Attorney, Australian Patent Attorney, New Zealand Patent Attorney


Principal, Patent Attorney

Joined Griffith Hack:
2003
Qualified as Patent Attorney:
1998 (UK)
Experience in Profession:
19 years
Location:
Melbourne

Contact Amanda
Download PDF Profile


Academic Qualifications:



  • Bachelor of Science (Hons) in Biochemistry – University of Bristol, UK (1986-1990)
  • Certificate in Intellectual Property Law – University of London (1994-1995)
  • Glasgow University UK – Post graduate research studying the plant enzyme shikimate dehydrogenase, particularly developing expression systems, purification methods and X-ray crystallography (1991)


Experience:



Whilst Amanda works exclusively in the biotechnology field, she is capable of understanding pharmaceutical chemistry and works closely with the chemical specialists in the group when needed. Amanda shares her time between managing the patent portfolios of overseas clients, including two of the world’s largest biotech companies and providing tailored strategic advice and expertise to local clients in the biotech sector. Her industrial experience helps to provide a commercial focus and she is often called on to provide due diligence, IPO and licensing advice. Amanda also trains and mentors junior biotech attorneys.

Amanda has particular experience in human and animal health, especially in vaccine technology, including adjuvants, peptide vaccines, for example for HIV and tuberculosis, viral vaccines, for example for influenza, vaccine delivery and carrier systems, having drafted and prosecuted patents in these areas and provided freedom to operate opinions for particular vaccine products. She has also drafted and prosecuted patents in several areas of human health, including stem cell technology and cellular reprogramming; cardiology; women’s health, particularly in relation to cervical cancer, ovarian cancer, infertility, pregnancy, menopause, contraception, anti-aging treatments and weight control; osteoporosis; diabetes and metabolic syndrome; inflammatory diseases; cancer; anti-infectives, especially anti-virals; immune suppressants; nutrition, especially infant formulas, neutraceuticals and nutrigenomics; and neurology, particularly in relation to dementia. Amanda also has substantial experience in medical devices, pesticides and herbicides and plant molecular biology.



Professional Affiliations:



  • British Chartered Institute of Patent Agents – fellow
  • Institute of Patent and Trade Mark Attorneys
  • Ausbiotech
  • LES
  • BioMelbourne Network

Specialisations:



  • Antibodies
  • Biochemistry
  • Biosimilars & Data Exclusivity
  • Biotechnology
  • Crystal structures
  • Food science
  • Immunology




  • Molecular Biology, Genetics & Genomics
  • Nutraceuticals
  • Peptide chemistry
  • Plants
  • Protein Chemistry
  • X ray crystallography
  • Vaccines


Speaking Engagements:



February 2011 - AusBiotech member briefing: The gene patent debate: the rest of the story
July 2011 - Tonkin's 2nd Annual Pharmaceutical Law Conference

Thought Leadership:



February 2012 - Patent trends for Alzheimer's disease
February 2012 - Clearing the fog: Patenting trends for the treatment of Alzheimer's disease